BiomarkerBay

Your facilitator in biomarker services, bioanalysis, and sample collection. Facility

Your facilitator in biomarker services, bioanalysis, and sample collection.

BiomarkerBay offers services for clinical validation in sample collections and biobanks in different indication areas.

We provide solutions to your biomarker questions by bringing together sample collections, academic knowledge, clinical and bioanalytical expertise in biomarker analysis, assay development, discovery, and clinical validation.

Our added value is:

Integration of biomarker expertise in academia and CROs;
Collaboration with biobanks and patient cohorts;
Extensive database of biomarker assays validated in research and in clinical settings;
Collaboration with key opinion leaders in relevant therapeutic areas;
High flexibility in assay development and bioanalysis.

How we offer you support

UMCG researchers

Are you working on a novel biomarker assay that needs promotion?
Have you been contacted by an industrial partner for a biomarker validation study but don’t know how to start a proposal?

If your answer is YES to either of these questions, please do not hesitate to contact us. If you are in doubt, please contact us so that we can offer you advise.

External companies

Are you looking for a biomarker or clinical expert in a specific indication area?
Are you interested in finding a sample collection to validate your biomarker?
Are you looking for expertise to develop or improve your biomarker assay?
Are you looking for a specific analysis to be performed on your samples?

If your answer is YES to any of these questions, please do not hesitate to contact us.

Biomarker analytical services

Expertise in oncology, asthma, COPD, Alzheimer’s disease;

Targeted and untargeted proteomics;

Multi-omics approach: genomics, transcriptomics, proteomics, lipidomics, and metabolomics.
Fit-For-Purpose Biomarker validation;

High flexibility in biomarker assay development, with high resolution LC-MS/MS analyses, ligand binding assays, imaging, and own or commercially available assays.
LC-MS/MS analysis of small and large molecules;

Multiplex ligand binding assays;

Biomarker pathways through multi-omics approaches;

Imaging biomarkers.
Collaborations with biobanks and patient cohorts;

Guidance on IVD development and registration;

Key opinion clinical experts in oncology, cardiometabolic disorders, neuroscience, respiratory disorders, inflammatory disorders, and haematology.
Collaborations with clinical biomarker experts;

Connection with patient cohorts and large population biobanks;

Setup for prospective collection for biomarker research.